Ετικέτες

Δευτέρα 28 Μαΐου 2018

Scholar : ΣΤΟΜΑΤΙΤΙΣ - νέα αποτελέσματ

Risk factors for periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: a case-control study

S Kettunen, U Lantto, P Koivunen, T Tapiainen… - European Journal of …, 2018
The etiology and pathogenesis of periodic fever, aphthous stomatitis, pharyngitis,
and adenitis (PFAPA) syndrome are unclear. We performed a case-control study to
evaluate potential environmental or lifestyle factors associated with PFAPA morbidity …
Google+ Facebook Twitter

[HTML] Stomatitis and VEGFR-Tyrosine Kinase Inhibitors (VR-TKIs): A Review of Current Literature in 4369 Patients

C Arena, G Troiano, A De Lillo, NF Testa, L Lo Muzio - BioMed Research International, 2018
Background. Multitargeted tyrosine kinase inhibitors (TKIs) represent a new class of
target-specific antineoplastic agents. These agents show some specific adverse
events such as fatigue/asthenia, anorexia/loss of appetite, dysgeusia …
Google+ Facebook Twitter

The association between interleukin polymorphism and recurrent aphthous stomatitis: A meta-analysis

D Wu, J Xin, J Liu, P Zhou - Archives of Oral Biology, 2018
Results Ten studies were included in the final meta-analysis, with 884 cases and
1104 controls participating. The results demonstrated that the polymorphism of IL-
1beta (− 511C/T) significantly increased the probability of the development of RAS in …
Google+ Facebook Twitter

Role of laser or photodynamic therapy in treatment of denture stomatitis: A systematic review

A Davoudi, B Ebadian, S Nosouhian - The Journal of Prosthetic Dentistry, 2018
Denture stomatitis (DS) is an inflammatory oral lesion that occurs mostly in elderly denture
wearers and that can negatively affect their quality of life. The conventional treatment
plan for DS is topical or systemic fungicidal drug therapy, which are not without side …
Google+ Facebook Twitter

[HTML] Budget Impact Analysis of Afatinib for First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Exon 19 …

J Graham, S Earnshaw, K Burslem, J Lim - Journal of Managed Care & Specialty …, 2018
… Neutropenia, 0.44, 0.00-1.29, Paronychia, 11.35, 7.25-15.45, Rash, 16.16,
11.40-20.91, Stomatitis, 8.73, 5.08-12.38, Erlotinib. Anemia, 1.19, 0.00-3.50,
17 … Paronychia, 0.33, 0.00-0.79, Rash, 3.13, 1.75-4.51, Stomatitis, 0.16 …
Google+ Facebook Twitter

[PDF] Therapeutic potential of Indian plants for the treatment of rheumatoid arthritis

P Pandey, S Tiwari - Journal of Pharmacognosy and Phytochemistry, 2018
… No. Drug Toxicities 1. Methotrexate(DMARDs) Stomatitis, rash, hepatotoxicity, rare but
potentially life-threatening pulmonary toxicity 2. Oral gold salts Diarrhea 3. Injectable
gold salts Stomatitis, myelosuppression, rash, thrombocytopenia …
Google+ Facebook Twitter

A recombinant virus vaccine that protects against both Chikungunya and Zika virus infections

A Chattopadhyay, PV Aguilar, NE Bopp, TO Yarovinsky… - Vaccine, 2018
… This vaccine is based on a chimeric vesicular stomatitis virus (VSV) that expresses the
CHIKV envelope polyprotein (E3-E2-6K-E1) in place of the VSV glycoprotein (G) and
also expresses the membrane-envelope (ME) glycoproteins of ZIKV …
Google+ Facebook Twitter

Immunohistological analysis of the duodenal bulb: a new method for celiac disease diagnosis in children

L De Leo, V Villanacci, F Ziberna, S Vatta, S Martelossi… - Gastrointestinal Endoscopy, 2018
… throughout the duodenum and with severe symptoms (3 with anemia, 3
recurrent aphtous stomatitis, 1 arthralgia and abdominal pain, 1 recurrent
abdominal pain) were diagnosed as having CD and were put on GFD … Anemia …
Google+ Facebook Twitter

[PDF] An Update on Drug-induced Oral Reactions

H Yousefi, M Abdollahi - Journal of Pharmacy & Pharmaceutical Sciences, 2018
… statistically significant. Recurrent aphthous stomatitis (RAS) is the most common
oral painful ulcerative inflammatory disease of unknown etiology; thereby its
management has been remained a challenge yet (25). Compelling …
Google+ Facebook Twitter

[HTML] Impact of race on dose selection of molecular-targeted agents in early-phase oncology trials

T Yokota, J Bendell, P LoRusso, T Tsushima, V Desai… - British Journal of Cancer, 2018
Article.
Google+ Facebook Twitter

 

Αυτή η ειδοποίηση αποστέλλεται από τον Μελετητή Google. Ο Μελετητής Google είναι μια υπηρεσία που παρέχεται από την Google.



Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αναζήτηση αυτού του ιστολογίου